StockData
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Alkermes plc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$42.97+1.75 (+4.25%)

Close on Oct 19, 2026

Market cap
$7.45B
P/E (TTM)
113.1
Dividend yield
–

Alkermes plc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
84.6%
Operating margin
7.0%
Net margin
4.0%
Return on equity, FY2025
14.7%

Financial strength

Current ratio
2.30
Debt to equity
0.83
Debt to assets
34.2%
Cash to current liabilities
77.3%

Valuation

P/E ratio
113.1
Price to sales
4.47
Price to book
4.12
Dividend yield
–